Framework review

There is a small piece of integrity in the unit here that is worth naming, because this page has spent a lot of effort on sellers who chose their denominator to flatter themselves. A GLP-1 is injected once a week. Pricing it by the week therefore describes something real: one figure, one injection. Compare that with the per-day pricing found elsewhere here, where a weekly drug was divided into thirty slices to produce a number that sounds like pocket change and corresponds to nothing a patient is charged. Framework's unit is the treatment's own. That said, a week is not a month, and the conversion is the trap: there are fifty-two weeks in a year rather than forty-eight, so multiplying by four and then by twelve understates the real figure by a month's worth. Anyone comparing this against the monthly rates that dominate the rest of the market should annualize first. Beyond the unit, the offer is stated cleanly — one price, no membership fee, dietitian and nutrition support bundled rather than sold as an upgrade, and both molecules named. What is missing is the usual: the figure is a floor with no ceiling, and no milligram sits behind it, so what quantity of drug a week actually buys is unstated.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Framework does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

There is a small piece of integrity in the unit here that is worth naming, because this page has spent a lot of effort on sellers who chose their denominator to flatter themselves. A GLP-1 is injected once a week. Pricing it by the week therefore describes something real: one figure, one injection. Compare that with the per-day pricing found elsewhere on this page, where a weekly drug was divided into thirty slices to produce a number that sounds like pocket change and corresponds to nothing a patient is charged. Framework's unit is the treatment's own. That said, a week is not a month, and the conversion is the trap: there are fifty-two weeks in a year rather than forty-eight, so multiplying by four and then by twelve understates the real figure by a month's worth. Anyone comparing this against the monthly rates that dominate the rest of the market should annualize first. Beyond the unit, the offer is stated cleanly — one price, no membership fee, dietitian and nutrition support bundled rather than sold as an upgrade, and both molecules named. What is missing is the usual: the figure is a floor with no ceiling, and no milligram sits behind it, so what quantity of drug a week actually buys is unstated.

A week is not a month, and fifty-two weeks is not twelve times four.

• The figure is an "as low as" with no ceiling published.
• No dose sits behind it, so what a week buys is unstated.

Framework is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose